Literature DB >> 29301864

Effect of autotransplantation of a parathyroid gland on hypoparathyroidism after total thyroidectomy.

Anping Su1, Yanping Gong1, Wenshuang Wu1, Rixiang Gong1, Zhihui Li1, Jingqiang Zhu.   

Abstract

BACKGROUND: The effect of parathyroid autotransplantation on hypoparathyroidism is not fully understood. The purpose of the study was to determine the effect of autotransplantation of a parathyroid gland on the incidence of hypoparathyroidism and recovery of parathyroid function at 6 months after total thyroidectomy with central neck dissection for papillary thyroid carcinoma.
METHODS: All patients with autotransplantation of a parathyroid gland (no inadvertent parathyroidectomy) (group A), in situ preservation of all parathyroid glands (no autotransplantation and inadvertent parathyroidectomy) (group B) or inadvertent removal of a parathyroid gland (no autotransplantation) (group C) who underwent first-time total thyroidectomy with central neck dissection for papillary thyroid carcinoma between January 2013 and June 2016 were included retrospectively.
RESULTS: Of the 702 patients, 383, 297 and 22 were respectively included in the groups A, B and C. The overall rates of transient and permanent hypoparathyroidism were 37.6% and 1.0%. The incidence of transient hypoparathyroidism was 43.9, 29.0 and 45.5% (A vs B, P = 0.000; A vs C, P = 1.000), and the incidence of permanent hypoparathyroidism was 1.0, 0.7 and 4.5% (P > 0.05). The recovery rates of serum parathyroid hormone levels were 71.4, 72.2 and 66.0% at 6-month follow-up (P > 0.05).
CONCLUSION: Autotransplantation of a parathyroid gland does not affect the incidence of permanent hypoparathyroidism, but increases the risk of transient hypoparathyroidism when the rest of parathyroid glands are preserved in situ. At least 2 parathyroid glands should be preserved during total thyroidectomy with central neck dissection to prevent permanent hypoparathyroidism.
© 2018 The authors.

Entities:  

Keywords:  autotransplantation; hypoparathyroidism; parathyroid gland

Year:  2018        PMID: 29301864      PMCID: PMC8111321          DOI: 10.1530/EC-17-0313

Source DB:  PubMed          Journal:  Endocr Connect        ISSN: 2049-3614            Impact factor:   3.335


Introduction

Total thyroidectomy with central neck dissection has been adopted in many specialized endocrine surgery units for the treatment of papillary thyroid carcinoma (PTC) (1, 2, 3). However, central neck dissection, especially bilateral central neck dissection, always increases the risk of postoperative hypoparathyroidism (3). The reported incidence in the literature varies from 14 to 51.9% for transient hypoparathyroidism and 0–43% for permanent hypoparathyroidism (3, 4, 5, 6). Although transient hypoparathyroidism will recover within few months, it occasionally prolongs hospitalization or leads to readmission (4). Permanent hypoparathyroidism is a severe and potentially lethal complication. It not only increases the overall costs of thyroid surgery, but also accounts for the main category of thyroidectomy-related claims (7, 8). Hypoparathyroidism is caused by injury to the parathyroid glands from ligation of the blood supply, inadvertent or deliberate removal, improper use of electrocauterization or destruction due to hematoma formation (9, 10). Meticulous dissection is a preferred method to preserve parathyroid glands with their blood supply in situ and to prevent inadvertent parathyroidectomy. However, parathyroid glands are still devascularized or occasionally found in the surgical specimens because of the anatomic location. Autotransplantation of devascularized or unintentionally removed parathyroid glands is generally recommended to prevent postoperative hypoparathyroidism (10, 11). Some endocrine surgeons even adopted routine autotransplantation of at least 1 parathyroid gland or all identifiable parathyroid glands to minimize the incidence of permanent hypoparathyriodism (12, 13, 14, 15). However, several studies demonstrated that parathyroid autotransplantation increased the risk of transient and permanent hypoparathyroidism (16, 17, 18). In addition, a recent study found similar incidence of permanent hypoparathyriodism whether a parathyroid gland was autotransplanted or inadvertently excised (19). Inadvertent parathyroidectomy is commonly regarded as one of the risk factors of postoperative hypoparathyroidism (20, 21). Interestingly, some studies reported that it had no relationship to the complication (22, 23, 24), suggesting that rather than removal of one or more parathyroid glands, autotransplantation renders them dysfunctional and causes postoperative hypoparathyroidism. Therefore, the effect of parathyroid autotransplantation on postoperative hypoparathyroidism is not fully understood. In this study, we compared the patients with autotransplantation of a parathyroid gland to those with all the parathyroid glands preserved in situ and those with inadvertent removal of a parathyroid gland. The purpose of the study was to determine whether autotransplantation of a parathyroid gland affected the incidence of postoperative hypoparathyroidism and recovery of parathyroid function at 6 months after total thyroidectomy with central neck dissection for papillary thyroid carcinoma.

Methods

Patients

We retrospectively searched for all PTC patients who underwent first-time total thyroidectomy with central neck dissection (including lateral neck dissection) in the Department of Thyroid Surgery, West China Hospital of Sichuan University between January 2013 and June 2016. Those patients with autotransplantation of a parathyroid gland (no inadvertent parathyroidectomy) (group A), in situ preservation of all the parathyroid glands (no autotransplantation and inadvertent parathyroidectomy) (group B) or inadvertent removal of a parathyroid gland (no autotransplantation) (group C) were included for analyses. The patients with preoperative parathyroid dysfunction, resurgery, completion thyroidectomy, endoscopic thyroidectomy or loss of 6-month follow-up were excluded. Informed consent of at least 6-month follow-up was obtained from each patient. The study was approved by the Medical Ethics Committee of West China Hospital, Sichuan University.

Indications and surgical procedures of total thyroidectomy with lymph node dissection

In our department, the indications and surgical procedures of total thyroidectomy with lymph node dissection for PTC treatment have been described in detail previously (25, 26). Unilateral central neck dissection is performed routinely. All patients underwent therapeutic lateral neck dissection (preoperative fine-needle aspiration cytology). All surgical procedures were performed by an experienced surgeon (Zhu). Each parathyroid gland was tried to be preserved in situ intraoperatively. Thymectomy was avoided except for tumor invasion. Surgical specimens (thyroid gland and central lymphadenectomy specimen) were examined routinely for any unintentionally removed parathyroid glands. If a parathyroid gland was nonviable or resected unintentionally, it was autotransplanted into the contralateral sternocleidomastoid muscle after the confirmation by intraoperative frozen biopsy. Precise information on the number of parathyroid glands identified and autotransplanted was recorded in operative notes. A same group of experienced pathologists analyzed all surgical specimens. The presence of a whole parathyroid gland or parathyroid tissue fragments (≤1 mm) in the perithyroidal area and/or the central lymphadenectomy specimen reported by pathologists was defined as inadvertent parathyroidectomy (2).

Perioperative management

Each patient accepted preoperative assessment including serum calcium, parathyroid hormone (PTH), thyroid function, neck ultrasound and laryngoscopy. The levels of serum calcium and PTH were routinely obtained on the first postoperative day and 1 month and 6 months after surgery. Intravenous calcium supplementation (calcium gluconate 10%, 40 mL) was routinely applied at the end of surgery. A standard dose of calcium carbonate (600–2400 mg/day) was orally administered on the first postoperative day if the serum PTH level was below the normal range. Calcitriol at 0.25–0.5 μg/day was simultaneously taken to promote absorption and reabsorption of calcium. Patients with normal PTH levels were not treated with oral calcium. Intravenous calcium was supplemented for the treatment of symptomatic hypocalcemia regardless of oral calcium and calcitriol administration. Oral calcium and calcitriol were ceased within 1 month after hospital discharge if possible. Hypoparathyroidism was defined as serum PTH level <1.6 pmol/L after surgery (normal range, 1.6–6.9 pmol/L). If serum PTH level returned to normal within 6 months postoperatively, hypoparathyroidism was classified as transient. On the contrary, it was classified as permanent if it persisted more than 6 months (27).

Data collection

The demographic characteristics, preoperative assessment, details of surgical extent (unilateral or bilateral central neck dissection), number of parathyroid glands identified, autotransplanted and inadvertently removed, final pathology, incidence of postoperative hypoparathyroidism and serum PTH levels at 6-month follow-up of all included patients were collected. Operative notes and pathology reports were reviewed independently by two authors (Su A and Gong Y) to determine the detail of parathyroid glands. PTC was staged by the system of American Joint Committee on Cancer (AJCC) (the 7th edition) (28). The primary endpoints were the number of parathyroid glands identified, autotransplanted and inadvertently removed, incidence of postoperative hypoparathyroidism and serum PTH levels at 6-month follow-up.

Statistical analysis

Continuous variables were expressed as mean ± s.d. The data were analyzed by SPSS software (version 19.0, SPSS, Inc., 1989–2010). Statistical comparison between groups A and B or groups A and C was calculated by the Fisher’s exact test or Student’s t-test. Multivariate analyses were performed to assess the independent risk factors of transient and permanent hypoparathyroidism. For multivariate analyses, the variables that were statistically significant in univariate analyses were included in logistic regression analyses. The results of the multivariate analyses were expressed as odds ratio (OR) and 95% confidence interval (CI). Statistical significance was set at P < 0.05.

Results

Patient characteristics

Of the 1492 patients whose medical records were reviewed, 702 met the study criteria and were included in the study (Fig. 1). There were 192 male and 510 female, with a mean age of 42.6 ± 12.9 years. Unilateral central neck dissection and bilateral central neck dissection were performed on 253 and 356 patients, respectively. Seventy-seven patients underwent bilateral central neck dissection with unilateral neck dissection, and 16 accepted bilateral central neck dissection with bilateral neck dissection. Groups A, B and C consisted of 383, 297 and 22 patients, respectively. Table 1 shows a comparison of baseline characteristics of the patients in the 3 groups. No significant differences were found between groups A and B or groups A and C in age, gender, body mass index (BMI), comorbidities (hypertension, diabetes, thyroiditis, Graves’ disease, hypothyroidism and nodular goiter) and preoperative levels of serum calcium and PTH. Patients with autotransplantation of a parathyroid gland underwent more bilateral central neck dissection than those with preservation of all the parathyroid glands in situ (67.4% vs 58.6%, P = 0.020).
Figure 1

Flow chart of the patients investigated. FTC, follicular thyroid carcinoma; LT, lobectomy; MEN, multiple endocrine neoplasia; MTC, medullary thyroid carcinoma; NG, nodular goiter; PTC, papillary thyroid carcinoma; TT, total thyroidectomy; UCND, unilateral central neck dissection.

Table 1

The clinical characteristics of the patients in the 3 groups.

VariablesGroup A (n = 383)Group B (n = 297)Group C (n = 22)P value*P value
Age (years)42.8 ± 12.842.3 ± 13.243.7 ± 10.30.6430.736
Gender (male/female)112/27175/2225/170.2610.633
BMI (kg/m2)23.6 ± 3.423.2 ± 3.422.8 ± 2.50.0820.275
Hypertension4736110.495
Diabetes11700.8111
Thyroiditis1167780.2300.635
Graves’ disease12710.6420.522
Hypothyroidism3500.3061
Nodular goiter22817590.8750.118
Calcium (mmol/L)2.32 ± 0.372.30 ± 0.222.31 ± 0.110.3220.859
PTH (pmol/L)5.42 ± 1.655.65 ± 2.275.74 ± 1.820.4210.553
Surgical extent (UCND/≥BCND)125/258123/1745/170.0200.481

*Groups A vs B; †groups A vs C.

BCND, bilateral central neck dissection; BMI, body mass index; PTH, parathyroid hormone; UCND, unilateral central neck dissection.

Flow chart of the patients investigated. FTC, follicular thyroid carcinoma; LT, lobectomy; MEN, multiple endocrine neoplasia; MTC, medullary thyroid carcinoma; NG, nodular goiter; PTC, papillary thyroid carcinoma; TT, total thyroidectomy; UCND, unilateral central neck dissection. The clinical characteristics of the patients in the 3 groups. *Groups A vs B; †groups A vs C. BCND, bilateral central neck dissection; BMI, body mass index; PTH, parathyroid hormone; UCND, unilateral central neck dissection.

Characteristics of tumors and central lymph nodes

Table 2 shows the characteristics of tumors and central lymph nodes. There were no significant differences between groups A and B or groups A and C in the largest tumor size, multifocality, primary tumor location, T classification, N classification, AJCC stage and gross extrathyroidal extension. Significantly more central lymph nodes and metastatic central lymph nodes were retrieved in the group A than in the group B (P = 0.001 and P = 0.024, respectively). However, there was no significant difference of the two parameters between groups A and C (P = 0.731 and P = 0.368, respectively).
Table 2

The characteristics of tumors and central lymph nodes in the 3 groups.

VariablesGroup A (n = 383)Group B (n = 297)Group C (n = 22)P valueP value
Largest tumor size (mm)14.4 ± 9.713.2 ± 9.913.6 ± 7.60.1330.709
Multifocality1067030.2510.216
Primary tumor location10.217
 Upper108843
 Middle16212214
 Lower103803
 Isthmus10112
T classification0.3840.655
 T11451237
 T21281
 T320615814
 T42080
N classification0.0790.822
 N01321228
 N125117514
AJCC stage
 I–II2501941110.171
 III–IV13310311
Gross extrathyroidal extension15512350.8140.118
Number of harvested lymph nodes*12.2 ± 6.510.6 ± 6.111.7 ± 6.50.0010.731
Number of metastatic lymph nodes*3.1 ± 4.22.5 ± 3.52.3 ± 3.20.0240.368

*Central lymph nodes; †groups A vs B; ‡groups A vs C.

AJCC, American Joint Committee on Cancer.

The characteristics of tumors and central lymph nodes in the 3 groups. *Central lymph nodes; †groups A vs B; ‡groups A vs C. AJCC, American Joint Committee on Cancer.

Details of parathyroid glands, hypoparathyroidism and 6-month follow-up

Among the 3 groups, less parathyroid glands were identified intraoperatively in the patients with inadvertent removal of a parathyroid gland. Rates of transient and permanent hypoparathyroidism for the entire cohort were 37.6% (264/702) and 1.0% (7/702), respectively. The incidence of transient hypoparathyroidism was 43.9% (168/383) in patients with autotransplantation of a parathyroid gland, 29.0% (86/297) in those with preservation of all the parathyroid glands and 45.5% (10/22) in those with inadvertent removal of a parathyroid gland (43.9% vs 29.0%, P = 0.000 and 43.9% vs 45.5%, P = 1.000). The incidence of permanent hypoparathyroidism in the 3 groups was 1.0, 0.7 and 4.5%, respectively (P > 0.05). Table 3 shows the serum PTH levels in the 3 groups at 6-month follow-up. Compared to the patients with in situ preservation of all the parathyroid glands, significantly lower serum PTH level was found in patients with autotransplantation of a parathyroid gland on postoperative day 1. However, similar levels of serum PTH were found in the 3 groups after 1 month and 6 months (P > 0.05). After 6 months of follow-up, the recovery rates of serum PTH level were 71.4, 72.2 and 66.0% in the 3 groups.
Table 3

The details of parathyroid glands, hypoparathyroidism and the results of follow-up in the 3 groups.

VariablesGroup A (n = 383)Group B (n = 297)Group C (n = 22)P value*P value
Parathyroid identification3.5 ± 0.83.4 ± 0.82.7 ± 0.80.6770.000
Hypoparathyroidism
 Transient16886100.0001
 Permanent4210.7010.245
Postoperative PTH (pmol/L)
 1 day1.76 ± 1.182.34 ± 1.411.93 ± 1.340.0010.664
 1 month3.45 ± 1.633.74 ± 1.703.50 ± 1.650.2200.920
 6 months3.87 ± 1.614.08 ± 1.613.79 ± 1.630.3720.879

*Groups A vs B; †groups A vs C.

PTH, parathyroid hormone.

The details of parathyroid glands, hypoparathyroidism and the results of follow-up in the 3 groups. *Groups A vs B; †groups A vs C. PTH, parathyroid hormone.

Risk factors for transient and permanent hypoparathyroidism

Perioperative factors, which influenced the incidence of transient and permanent hypoparathyroidism, were sought by univariate and multivariate analyses. Gender, surgical extent and parathyroid autotransplantation had significant effects on the formation of transient hypoparathyroidism and the number of parathyroid glands preserved in situ was associated with permanent hypoparathyroidism on univariate analyses (Table 4). Multivariate analysis found female, bilateral central neck dissection and autotransplantation of a parathyroid gland to be independent risk factors of transient hypoparathyroidism (Table 5). Preservation of less than 2 parathyroid glands was an independent risk factor of permanent hypoparathyroidism (OR, 9.085; 95% CI, 1.981–44.660; P = 0.005).
Table 4

Univariate analysis of risk factors for the development of transient and permanent hypoparathyroidism.

VariablesNo permanentPermanent (n = 7)P valueP value
Normal (n = 431)Transient (n = 264)Total (n = 695)
Age (<45/≥45, years)241/190152/112393/3022/50.6940.250
Gender (male/female)138/29353/211191/5041/60.0010.680
BMI (<25/≥25, kg/m2)303/128195/69498/1975/20.3401
Hypertension57268310.2280.592
Diabetes1261800.8081
Thyroiditis1217819920.7301
Graves’ disease1282000.8201
Hypothyroidism538011
Nodular goiter25115840930.6920.456
Preoperative calcium (mmol/L)2.31 ± 0.162.32 ± 0.44 2.31 ± 0.302.26 ± 0.090.6580.676
Preoperative PTH (pmol/L)5.73 ± 1.985.28 ± 1.755.54 ± 1.164.28 ± 2.330.1450.129
Surgical extent (UCND/≥BCND)172/25979/185251/4442/50.0091
Largest tumor size (mm)13.6 ± 8.414.6 ± 10.314.0 ± 9.214.4 ± 5.40.2230.832
Multifocality1017617720.1271
Tumor location (upper/middle/lower/isthmus)127/174/116/1464/121/70/9191/295/186/234/3/0/00.1380.098
T classification (T1–2/T3–4)175/256118/146293/4023/40.3041
N classification (N0/N1)166/26594/170260/4352/50.4681
AJCC stage (I–II/III–IV)272/159179/85451/2444/30.2200.701
Gross extrathyroidal extension174106280311
Harvested lymph nodes (<10/≥10)*205/226107/157312/3835/20.0710.254
Parathyroid identification (<3/≥3)55/37639/22594/6013/40.4930.059
Parathyroid autotransplantation (0/1)220/21196/168 316/3793/4 0.0001
Inadvertent parathyroidectomy (0/1)420/11254/10674/216/10.3690.201
Parathyroid preservation (<2/≥2)29/40223/24152/6433/40.3730.013

*Central lymph nodes; †normal vs transient; ‡no permanent (total) vs permanent.

AJCC, American Joint Committee on Cancer; BCND, bilateral central neck dissection; BMI, body mass index; PTH, parathyroid hormone; UCND, unilateral central neck dissection.

Table 5

Multivariate analysis of risk factors for the development of transient hypoparathyroidism.

VariablesOR95% CIP value
Gender (female)1.9771.366–2.8610.000
Surgical extent (≥BCND)1.5541.114–2.1680.009
Parathyroid autotransplantation (1)1.8341.332–2.5260.000

BCND, bilateral central neck dissection; CI, confidence interval; OR, odds ratio. (1) autotransplantation of one parathyroid gland increases the incidence of transient hypoparathyroidism.

Univariate analysis of risk factors for the development of transient and permanent hypoparathyroidism. *Central lymph nodes; †normal vs transient; ‡no permanent (total) vs permanent. AJCC, American Joint Committee on Cancer; BCND, bilateral central neck dissection; BMI, body mass index; PTH, parathyroid hormone; UCND, unilateral central neck dissection. Multivariate analysis of risk factors for the development of transient hypoparathyroidism. BCND, bilateral central neck dissection; CI, confidence interval; OR, odds ratio. (1) autotransplantation of one parathyroid gland increases the incidence of transient hypoparathyroidism.

Discussion

Parathyroid autotransplantation, first described in humans by Lahey in 1926 (29), is regarded as a major technical and physiological breakthrough in the field of thyroid surgery. In recent years, it has been increasingly employed to prevent postoperative hypoparathyroidism (10, 11, 12, 13, 14, 15). However, there is no good evidence to prove that parathyroid grafts do in fact prevent this complication because the recovery of parathyroid function depends on both preserved and autotransplanted parathyroid glands (19). As shown in the present study, there is large consensus that autotransplantation increases the risks of transient hypoparathyroidism and postoperative hypocalcemia (8, 30, 31). It is still controversial whether it can reduce the incidence of permanent hypoparathyroidism. Although two studies reported that autotransplantation of all identifiable parathyroid glands could lower the risk of permanent hypoparathyroidism (14, 15), Kihara and coworkers (17) found that the strategy led to a higher permanent hypoparathyroidism rate. The effect of autotransplantation on permanent hypoparathyroidism is closely related to the number of autotransplanted parathyroid glands (8, 17). Kikumori and coworkers (15) revealed that the incidence of permanent hypoparathyroidism was inversely correlated with the number of autotransplanted parathyroid glands. Several studies reported that autotransplantation of at least one parathyroid gland effectively decreased the incidence of permanent hypoparathyroidism (12, 13, 30). A multicenter study also investigated the impact of autotransplantation of a parathyroid gland on postoperative hypoparathyroidism and drew a similar conclusion (32). These conclusions, however, are questioned by the confounding factors, including different number of parathyroid glands autotransplanted and preserved, a variety of thyroid gland disorders (benign and malignant tumors) and different surgical times (first-time surgery and resurgery). In addition, these studies did not provide the comparison with inadvertent parathyroidectomy and the change of serum PTH levels after follow-up. There is no doubt that parathyroid autotransplantation is an effective procedure to preserve parathyroid function. Direct evidence of grafts function can be obtained through the comparison of serum PTH levels between the transplanted and non-transplanted arms (33, 34). The reported success rate of autotransplantation ranges from 55 to 100% (5). In our study, although there was no significant difference of the serum PTH levels among the 3 groups at 6-month follow-up, the recovery rates were higher in patients with autotransplantation of a parathyroid gland or in situ preservation of all the parathyroid glands than those with inadvertent removal of a parathyroid gland (71.4%/72.2% vs 66.0%). The parathyroid function of the patients without inadvertent parathyroidectomy in the 2 groups did not recover to 100% of the preoperative levels at 6-month follow-up, which is attributed to the thermal and/or mechanical injury of parathyroid glands, dysfunction of parathyroid glands preserved in situ, loss of part of parathyroid tissue for intraoperative frozen biopsy, dysfunction of the grafts and/or short-term follow-up period. Most available reports on parathyroid autotransplantation have overestimated its impact and underestimated the effect of in situ preservation on parathyroid function (12, 13, 30, 32). In our study, the prevalence of permanent hypoparathyroidism after total thyroidectomy with central lymph node dissection was similar whether a parathyroid gland was autotransplanted, preserved or inadvertently removed when the rest of parathyroid glands were preserved in situ. This observation implies that the part of function preserved by autotransplantation of a parathyroid gland has no significant effect on the incidence of permanent hypoparathyroidism. Therefore, parathyroid glands preserved in situ, instead of the one autotransplanted, are critical in preventing permanent hypoparathyroidism (2). This finding can be explained by the fact that preserving at least 2 parathyroid glands with an intact blood supply is sufficient to prevent permanent hypoparathyroidism (35). The current study also demonstrated that in situ preservation of less than 2 parathyroid glands was a significant variable favoring permanent hypoparathyroidism. Therefore, at least 2 parathyroid glands should be carefully preserved during total thyroidectomy with central neck dissection to avoid permanent hypoparathyroidism. Intraoperative identification of parathyroid glands is negatively correlated with inadvertent removal of parathyroid glands (36). Inadvertent parathyroidectomy is always reported to add a further risk of postoperative transient and permanent hypoparathyroidism (20, 21, 37). A recent study revealed that presence of at least 2 parathyroid glands in surgical specimens was a risk factor of transient hypoparathyroidism (38). However, one study revealed no correlation between inadvertent parathyroidectomy and permanent hypoparathyroidism (27). Current evidence suggested that inadvertent removal of a parathyroid gland had no statistically significant relation with permanent hypoparathyroidism, which is similar to the finding of the study. It further confirms that in situ preservation of at least 2 parathyroid glands effectively prevents permanent hypoparathyroidism. As reported in the previous studies (12, 17), female gender was an independent risk factor of transient hypoparathyroidism in the present study. However, the exact mechanisms underlying the gender disparity are still not clear. It may attribute to the anatomic and morphologic differences of parathyroid glands, different effects of sex steroids on PTH secretion and different regulators of monoclonal proliferation and mitosis of parathyroid glands between male and female patients (39, 40, 41). Bilateral central neck dissection involves high risk of hypoparathyroidism due to the devascularization and/or inadvertent removal of parathyroid glands (37, 38). Patients with bilateral central neck dissection frequently suffer from higher rates of transient and permanent hypoparathyroidism than those with unilateral central neck dissection (6). According to data from the present study, however, bilateral central neck dissection had no close relationship with permanent hypoparathyroidism. This result appears to be relevant to the surgeon’s experience, which is of utmost importance to prevent permanent hypoparathyroidism (42). Therefore, patients may benefit from an experienced surgeon to perform total thyroidectomy with bilateral central neck dissection. There are several limitations in the study. The data are from retrospective chart review. The effect of autotransplantation of a parathyroid gland is determined on the basis of the recovery of parathyroid function which depends on both the in situ normal parathyroid glands and the autotransplanted parathyroid glands. Neither the viability of the preserved parathyroid glands nor the graft function could be assessed directly. Another limitation is the short-term follow-up period. Therefore, the result will be more persuasive if a prospective trial with autotransplantation of a parathyroid gland in the forearm subcutaneous tissue or muscle and with long-term follow-up period is conducted in the future. In conclusion, autotransplantation of a parathyroid gland does not affect the incidence of permanent hypoparathyroidism, but increases the risk of transient hypoparathyroidism when the rest of parathyroid glands are preserved in situ. At least 2 parathyroid glands should be preserved during total thyroidectomy with central neck dissection to prevent permanent hypoparathyroidism.

Declaration of interest

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.

Funding

This study was supported by the National Natural Science Fund (81502612) and Scientific Research Fund of Science and Technology Department of Sichuan Province (2016SZ0045).

Author contribution statement

Anping Su helped in writing and revising the manuscript. Yanping Gong, Wenshuang Wu, Rixiang Gong and Zhihui Li helped in revising the manuscript. Jingqiang Zhu helped in revising the manuscript and is a corresponding author.
  39 in total

1.  Complications in thyroid surgery for carcinoma: one institution's surgical experience.

Authors:  Antonio Toniato; Isabella Merante Boschin; Andrea Piotto; Maria Rosa Pelizzo; Annamaria Guolo; Mirto Foletto; Eric Casalide
Journal:  World J Surg       Date:  2008-04       Impact factor: 3.352

Review 2.  Lymph node dissection in patients with differentiated thyroid carcinoma--who benefits?

Authors:  B Mann; H J Buhr
Journal:  Langenbecks Arch Surg       Date:  1998-10       Impact factor: 3.445

Review 3.  Systematic review and meta-analysis of predictors of post-thyroidectomy hypocalcaemia.

Authors:  O Edafe; R Antakia; N Laskar; L Uttley; S P Balasubramanian
Journal:  Br J Surg       Date:  2014-01-09       Impact factor: 6.939

4.  Routine parathyroid autotransplantation during thyroidectomy.

Authors:  C Y Lo; K Y Lam
Journal:  Surgery       Date:  2001-03       Impact factor: 3.982

5.  Outcomes of Parathyroid Autotransplantation During Total Thyroidectomy: A Comparison with Age- and Sex-Matched Controls.

Authors:  Turkay Kirdak; Halit Ziya Dundar; Erdal Uysal; Gokhan Ocakoglu; Nusret Korun
Journal:  J Invest Surg       Date:  2016-10-04       Impact factor: 2.533

6.  Our technique of parathyroid autotransplantation in operation for papillary thyroid carcinoma.

Authors:  H Funahashi; Y Satoh; T Imai; M Ohno; T Narita; M Katoh; Y Tanaka; J Tobinaga; H Andoh; K Miyazaki
Journal:  Surgery       Date:  1993-07       Impact factor: 3.982

7.  Parathyroid reimplantation with PR-FaST technique in unselected patients during thyroidectomy. A case series with long term follow up confirming graft vitality and parathormone production.

Authors:  Giuseppe Cavallaro; Olga Iorio; Marco Centanni; Lucilla Gargano; Susanna Del Duca; Angela Gurrado; Natale Porta; Vincenzo Petrozza; Mario Testini; Giorgio De Toma
Journal:  Int J Surg       Date:  2017-02-03       Impact factor: 6.071

8.  Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence.

Authors:  Chad M Hall; Samuel K Snyder; Yolanda Muñoz Maldonado; Terry C Lairmore
Journal:  Surgery       Date:  2016-08-09       Impact factor: 3.982

9.  Incidence of inadvertent parathyroid removal during thyroidectomy.

Authors:  Derrick T Lin; Snehal G Patel; Ashok R Shaha; Bhuvanesh Singh; Jatin P Shah
Journal:  Laryngoscope       Date:  2002-04       Impact factor: 3.325

10.  Risk factors of hypoparathyroidism following total thyroidectomy with central lymph node dissection.

Authors:  Anping Su; Bin Wang; Yanping Gong; Rixiang Gong; Zhihui Li; Jingqiang Zhu
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

View more
  12 in total

1.  Surgical strategy when identifying less than four parathyroid glands during total thyroidectomy: a retrospective cohort study.

Authors:  Zhichao Xing; Yuxuan Qiu; Baoying Xia; Munire Abuduwaili; Yuan Fei; Jingqiang Zhu; Anping Su
Journal:  Gland Surg       Date:  2021-01

2.  The effectiveness of parathyroid gland autotransplantation in preserving parathyroid function during thyroid surgery for thyroid neoplasms: A meta-analysis.

Authors:  Bin Wang; Chun-Rong Zhu; Hong Liu; Jian Wu
Journal:  PLoS One       Date:  2019-08-14       Impact factor: 3.240

3.  Protective strategy of parathyroid glands during thyroid lobectomy: A retrospective cohort and case-control study.

Authors:  Zhichao Xing; Yuxuan Qiu; Yuan Fei; Baoying Xia; Munire Abuduwaili; Jingqiang Zhu; Anping Su
Journal:  Medicine (Baltimore)       Date:  2021-04-09       Impact factor: 1.817

4.  The Effect of Parathyroid Gland Autotransplantation on Hypoparathyroidism After Thyroid Surgery for Papillary Thyroid Carcinoma.

Authors:  Bin Wang; Chun-Rong Zhu; Xin-Min Yao; Jian Wu
Journal:  Cancer Manag Res       Date:  2021-08-24       Impact factor: 3.989

5.  Effects of Central Neck Dissection on Complications in Differentiated Thyroid Cancer.

Authors:  Mehmet Taner Unlu; Nurcihan Aygun; Zeynep Gul Demircioglu; Adnan Isgor; Mehmet Uludag
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2021-09-24

6.  The Ability of Near-Infrared Autofluorescence to Protect Parathyroid Gland Function During Thyroid Surgery: A Meta-Analysis.

Authors:  Bin Wang; Chun-Rong Zhu; Hong Liu; Xin-Min Yao; Jian Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-25       Impact factor: 5.555

7.  Parathyroid autotransplantation at a novel site for better evaluation of the grafted gland function: study protocol for a prospective, randomized controlled trial.

Authors:  Qiuxia Cui; Deguang Kong; Zhihua Li; Kun Wang; Dan Zhang; Jianing Tang; Xing Liao; Qianqian Yuan; Yan Gong; Gaosong Wu
Journal:  Trials       Date:  2019-01-31       Impact factor: 2.279

8.  The inferior parathyroid glands preserved in site recover faster than the superior parathyroid glands preserved in site after thyroid surgery for carcinoma.

Authors:  Bin Wang; Chun-Rong Zhu; Hong Liu; Xin-Min Yao; Jian Wu
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

9.  Risk factors and prediction of postoperative hypoparathyroidism among patients with papillary thyroid carcinoma.

Authors:  Shi-Hang Xue; Zhi-Yu Li; Wei-Zhu Wu
Journal:  Transl Cancer Res       Date:  2019-04       Impact factor: 1.241

Review 10.  Heterogeneity in Utilization of Optical Imaging Guided Surgery for Identifying or Preserving the Parathyroid Glands-A Meta-Narrative Review.

Authors:  Eline A Feitsma; Hugo M Schouw; Milou E Noltes; Wido Heeman; Wendy Kelder; Gooitzen M van Dam; Schelto Kruijff
Journal:  Life (Basel)       Date:  2022-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.